Vident Advisory’s Teva Pharmaceuticals TEVA Stock Holding History

Vident Advisory’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$666K	Sell
2025 Q1	$666K	Buy
2024 Q4	$951K	Sell
2024 Q3	$820K	Sell
2024 Q2	$757K	Buy
2024 Q1	–	Sell
2023 Q4	$425K	Buy
2023 Q3	$297K	Buy